Logo image of CRUS

CIRRUS LOGIC INC (CRUS) Stock Fundamental Analysis

NASDAQ:CRUS - Nasdaq - US1727551004 - Common Stock - Currency: USD

98.2  +2.66 (+2.78%)

After market: 98.2 0 (0%)

Fundamental Rating

7

Overall CRUS gets a fundamental rating of 7 out of 10. We evaluated CRUS against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making CRUS a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on CRUS. These ratings would make CRUS suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CRUS was profitable.
In the past year CRUS had a positive cash flow from operations.
CRUS had positive earnings in each of the past 5 years.
CRUS had a positive operating cash flow in each of the past 5 years.
CRUS Yearly Net Income VS EBIT VS OCF VS FCFCRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of CRUS (12.91%) is better than 83.64% of its industry peers.
CRUS has a Return On Equity of 15.54%. This is in the better half of the industry: CRUS outperforms 77.27% of its industry peers.
With an excellent Return On Invested Capital value of 12.68%, CRUS belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
CRUS had an Average Return On Invested Capital over the past 3 years of 13.35%. This is above the industry average of 11.32%.
Industry RankSector Rank
ROA 12.91%
ROE 15.54%
ROIC 12.68%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
CRUS Yearly ROA, ROE, ROICCRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CRUS's Profit Margin of 16.55% is fine compared to the rest of the industry. CRUS outperforms 74.55% of its industry peers.
CRUS's Profit Margin has improved in the last couple of years.
CRUS's Operating Margin of 20.44% is fine compared to the rest of the industry. CRUS outperforms 78.18% of its industry peers.
CRUS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 52.18%, CRUS is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
CRUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.44%
PM (TTM) 16.55%
GM 52.18%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
CRUS Yearly Profit, Operating, Gross MarginsCRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRUS is still creating some value.
The number of shares outstanding for CRUS has been reduced compared to 1 year ago.
CRUS has less shares outstanding than it did 5 years ago.
CRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRUS Yearly Shares OutstandingCRUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRUS Yearly Total Debt VS Total AssetsCRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CRUS has an Altman-Z score of 9.73. This indicates that CRUS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.73, CRUS belongs to the best of the industry, outperforming 82.73% of the companies in the same industry.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.73
ROIC/WACC1.33
WACC9.54%
CRUS Yearly LT Debt VS Equity VS FCFCRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CRUS has a Current Ratio of 5.93. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.93, CRUS belongs to the best of the industry, outperforming 82.73% of the companies in the same industry.
CRUS has a Quick Ratio of 4.62. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.62, CRUS is doing good in the industry, outperforming 79.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 4.62
CRUS Yearly Current Assets VS Current LiabilitesCRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.38% over the past year.
CRUS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.11% yearly.
CRUS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.99%.
CRUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.58% yearly.
EPS 1Y (TTM)13.38%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%-13.15%
Revenue 1Y (TTM)2.99%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%-10.22%

3.2 Future

CRUS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.91% yearly.
The Revenue is expected to grow by 5.11% on average over the next years.
EPS Next Y8.93%
EPS Next 2Y2.95%
EPS Next 3Y5.91%
EPS Next 5YN/A
Revenue Next Year6.84%
Revenue Next 2Y3.56%
Revenue Next 3Y5.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRUS Yearly Revenue VS EstimatesCRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CRUS Yearly EPS VS EstimatesCRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.79 indicates a correct valuation of CRUS.
Compared to the rest of the industry, the Price/Earnings ratio of CRUS indicates a rather cheap valuation: CRUS is cheaper than 86.36% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.22. CRUS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 14.04, CRUS is valued correctly.
82.73% of the companies in the same industry are more expensive than CRUS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. CRUS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.79
Fwd PE 14.04
CRUS Price Earnings VS Forward Price EarningsCRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRUS indicates a somewhat cheap valuation: CRUS is cheaper than 80.00% of the companies listed in the same industry.
CRUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRUS is cheaper than 97.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.41
EV/EBITDA 10.82
CRUS Per share dataCRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CRUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CRUS may justify a higher PE ratio.
PEG (NY)1.55
PEG (5Y)0.69
EPS Next 2Y2.95%
EPS Next 3Y5.91%

0

5. Dividend

5.1 Amount

No dividends for CRUS!.
Industry RankSector Rank
Dividend Yield N/A

CIRRUS LOGIC INC

NASDAQ:CRUS (5/2/2025, 8:00:01 PM)

After market: 98.2 0 (0%)

98.2

+2.66 (+2.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners96.13%
Inst Owner Change0.41%
Ins Owners0.43%
Ins Owner Change8.12%
Market Cap5.22B
Analysts80
Price Target123.03 (25.29%)
Short Float %2.85%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.57%
Min EPS beat(2)9.26%
Max EPS beat(2)15.88%
EPS beat(4)4
Avg EPS beat(4)48.33%
Min EPS beat(4)9.26%
Max EPS beat(4)89.62%
EPS beat(8)8
Avg EPS beat(8)39.59%
EPS beat(12)12
Avg EPS beat(12)37.02%
EPS beat(16)15
Avg EPS beat(16)30.95%
Revenue beat(2)2
Avg Revenue beat(2)4.42%
Min Revenue beat(2)2.07%
Max Revenue beat(2)6.77%
Revenue beat(4)4
Avg Revenue beat(4)9.76%
Min Revenue beat(4)2.07%
Max Revenue beat(4)15.17%
Revenue beat(8)7
Avg Revenue beat(8)7.77%
Revenue beat(12)11
Avg Revenue beat(12)8.55%
Revenue beat(16)14
Avg Revenue beat(16)6.75%
PT rev (1m)-7.81%
PT rev (3m)-7.22%
EPS NQ rev (1m)0.24%
EPS NQ rev (3m)17.11%
EPS NY rev (1m)0%
EPS NY rev (3m)8.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.68%
Valuation
Industry RankSector Rank
PE 13.79
Fwd PE 14.04
P/S 2.83
P/FCF 11.41
P/OCF 10.77
P/B 2.66
P/tB 3.47
EV/EBITDA 10.82
EPS(TTM)7.12
EY7.25%
EPS(NY)6.99
Fwd EY7.12%
FCF(TTM)8.6
FCFY8.76%
OCF(TTM)9.12
OCFY9.28%
SpS34.69
BVpS36.94
TBVpS28.28
PEG (NY)1.55
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 12.91%
ROE 15.54%
ROCE 17.51%
ROIC 12.68%
ROICexc 17.18%
ROICexgc 24.18%
OM 20.44%
PM (TTM) 16.55%
GM 52.18%
FCFM 24.8%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
ROICexc(3y)17.57%
ROICexc(5y)16.14%
ROICexgc(3y)27.26%
ROICexgc(5y)24.15%
ROCE(3y)18.43%
ROCE(5y)16.72%
ROICexcg growth 3Y3.78%
ROICexcg growth 5Y15.34%
ROICexc growth 3Y2.32%
ROICexc growth 5Y17.66%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 54.74%
Cap/Sales 1.48%
Interest Coverage 250
Cash Conversion 113.57%
Profit Quality 149.87%
Current Ratio 5.93
Quick Ratio 4.62
Altman-Z 9.73
F-Score7
WACC9.54%
ROIC/WACC1.33
Cap/Depr(3y)59.75%
Cap/Depr(5y)50.89%
Cap/Sales(3y)1.92%
Cap/Sales(5y)1.79%
Profit Quality(3y)113.36%
Profit Quality(5y)132.62%
High Growth Momentum
Growth
EPS 1Y (TTM)13.38%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%-13.15%
EPS Next Y8.93%
EPS Next 2Y2.95%
EPS Next 3Y5.91%
EPS Next 5YN/A
Revenue 1Y (TTM)2.99%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%-10.22%
Revenue Next Year6.84%
Revenue Next 2Y3.56%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
EBIT growth 1Y15.37%
EBIT growth 3Y13.28%
EBIT growth 5Y29.21%
EBIT Next Year19.05%
EBIT Next 3Y15.14%
EBIT Next 5YN/A
FCF growth 1Y-11.4%
FCF growth 3Y5.29%
FCF growth 5Y17.53%
OCF growth 1Y-11.84%
OCF growth 3Y6.52%
OCF growth 5Y15.33%